Multiple endocrine neoplasia type 2 (MEN 2) : This genetic disorder can increase the risk of developing MTC
Which Should I Choose
Active-comparator new-user cohort studies with an appropriate design have consistently demonstrated dementia risk reduction with SGLT2 inhibitor users with diabetes across different regions [12,13,14,15,16,17,18,19,20]
In de fase II-studie bij patinten met diabetes type 2 zijn 281 deelnemers gerandomiseerd naar doses van 0,5, 4, 8 of 12 mg retatrutide, de GLP1-receptoragonist dulaglutide 1,5 mg of placebo
it remains the gold standard with an unmatched ability to immediately stent the airway open and normalize breathing during sleep